Literature DB >> 22460615

Disparities in breast cancer mortality trends in a middle income country.

Ana Maria Pedraza1, Marina Pollán, Roberto Pastor-Barriuso, Anna Cabanes.   

Abstract

In recent decades, breast cancer cases have increased steadily worldwide. However, the increases do not hold across all demographics and breast cancer cases in low and middle income countries have increased much faster than the global trend. Colombia is not an exception. Breast cancer was the most frequent tumor and the second cause of cancer-related deaths in women in 2008, with an estimated of 6,700 new cases and 2,100 deaths. We present here an analysis of breast cancer mortality rates and trends in Colombia, over the period 1985-2008. We studied overall and age-specific changes in breast cancer mortality using change-point Poisson regression models. Between 1985 and 2008, there were 32,375 breast cancer deaths in women in Colombia. Breast cancer mortality increased since 1985, although the annual increase varied between age groups and socioeconomic levels. Only in women aged 45-64 years old that live in areas of high socioeconomic levels, breast cancer mortality was stable or decreasing. Hence, successful cancer control is possible in middle income countries, as shown by the progress observed in certain groups. The development of an integrated strategy of early detection and early access to proper treatment, suitable for areas with limited resources, is an urgent necessity.

Entities:  

Mesh:

Year:  2012        PMID: 22460615     DOI: 10.1007/s10549-012-2026-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

1.  Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.

Authors:  Wei Li; Ke-Jia Liu; Jing-Song Song; Rui Song; Zi-Liang Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.

Authors:  Xiying Shao; Jinwei Cai; Yabing Zheng; Jiwen Wang; Jianguo Feng; Yuan Huang; Lei Shi; Zhanhong Chen; Yong Guo; Xiaojia Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Rs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I-II and operable stage III breast cancer.

Authors:  Xiying Shao; Lei Luo; Yong Guo; Xiaohong Xu; Dehou Deng; Jianguo Feng; Yuheng Ding; Hanzhou Mou; Ping Huang; Lei Shi; Yuan Huang; Weiwu Ye; Caijin Lou; Zhanhong Chen; Yabing Zheng; Xiaojia Wang
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

Review 4.  Implementation science in cancer prevention and control: a framework for research and programs in low- and middle-income countries.

Authors:  Sudha Sivaram; Michael A Sanchez; Barbara K Rimer; Jonathan M Samet; Russell E Glasgow
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-09-01       Impact factor: 4.254

5.  Cervical and female breast cancers in the Americas: current situation and opportunities for action.

Authors:  Silvana Luciani; Anna Cabanes; Elisa Prieto-Lara; Vilma Gawryszewski
Journal:  Bull World Health Organ       Date:  2013-09-01       Impact factor: 9.408

6.  The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancer.

Authors:  Xiying Shao; Yong Guo; Xiaohong Xu; Yabing Zheng; Jiwen Wang; Zhanhong Chen; Jian Huang; Ping Huang; Jufen Cai; Xiaojia Wang
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis.

Authors:  Zhiwang Song; Chuan Shao; Chan Feng; Yonglin Lu; Yong Gao; Chunyan Dong
Journal:  Ther Clin Risk Manag       Date:  2016-05-12       Impact factor: 2.423

8.  Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.

Authors:  Begoña Pineda; Miguel Ángel García-Pérez; Antonio Cano; Ana Lluch; Pilar Eroles
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

9.  Socioeconomic disparities in breast cancer incidence and survival among parous women: findings from a population-based cohort, 1964-2008.

Authors:  Mandy Goldberg; Ronit Calderon-Margalit; Ora Paltiel; Wiessam Abu Ahmad; Yechiel Friedlander; Susan Harlap; Orly Manor
Journal:  BMC Cancer       Date:  2015-11-19       Impact factor: 4.430

10.  Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast-screening.

Authors:  Raúl Murillo; Sandra Díaz; Fernando Perry; César Poveda; Marion Piñeros; Oswaldo Sánchez; Lina Buitrago; Oscar Gamboa; Teófilo Lozano; Hsiang Yu; Ching-Yun Wang; Catherine Duggan; David B Thomas; Benjamin O Anderson
Journal:  Int J Cancer       Date:  2015-09-02       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.